Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8480879 | 8644955 | I | 8480879-7 | 20120618 | 20120630 | EXP | CH-ACCORD-013853 | ACCORDHCP | 62 | YR | F | Y | 20120628 | OT | SWITZERLAND |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8480879 | 1020136630 | SS | PREDNISONE TAB | 1 | 8 CYCLES | ||||||
| 8480879 | 1020136624 | PS | ETOPOSIDE | 1 | 074513 | ||||||
| 8480879 | 1020136629 | SS | PROCARBAZINE HYDROCHLORIDE | 1 | 8 CYCLES | ||||||
| 8480879 | 1020136625 | SS | DOXORUBICIN HCL | 1 | 8 CYCLES | ||||||
| 8480879 | 1020136626 | SS | VINCRISTINE | 1 | 8 CYCLES | ||||||
| 8480879 | 1020136628 | SS | CYCLOPHOSPHAMIDE | 1 | 8 CYCLES | ||||||
| 8480879 | 1020136627 | SS | BLEOMYCIN SULFATE | 1 | 8 CYCLES |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8480879 | 1020136630 | HODGKIN'S DISEASE RECURRENT |
| 8480879 | 1020136624 | HODGKIN'S DISEASE RECURRENT |
| 8480879 | 1020136629 | HODGKIN'S DISEASE RECURRENT |
| 8480879 | 1020136625 | HODGKIN'S DISEASE RECURRENT |
| 8480879 | 1020136626 | HODGKIN'S DISEASE RECURRENT |
| 8480879 | 1020136628 | HODGKIN'S DISEASE RECURRENT |
| 8480879 | 1020136627 | HODGKIN'S DISEASE RECURRENT |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8480879 | OT |
| 8480879 | DS |
Reactions reported
| Event ID | PT |
|---|---|
| 8480879 | JC VIRUS INFECTION |
| 8480879 | OFF LABEL USE |
| 8480879 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |